{"id":1760,"date":"2023-01-02T14:29:51","date_gmt":"2023-01-02T13:29:51","guid":{"rendered":"https:\/\/www.inem.cnrs.fr\/?page_id=1760"},"modified":"2023-02-02T12:19:25","modified_gmt":"2023-02-02T11:19:25","slug":"brevets","status":"publish","type":"page","link":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/","title":{"rendered":"Brevets"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Liste des brevets<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Brevet europ\u00e9en d\u00e9pos\u00e9 le 04 mars 2021 : N\u00b0 EP21305260<\/span><\/span><\/p>\n

USE OF A PERIOSTIN ANTIBODY FOR TREATING INFLAMMATION, FIBROSIS AND LUNG DISEASES
Inventeurs : M.Perez-Cruz et B.Ryffel (CNRS)
<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Brevet WO\/2013\/001412 publi\u00e9 le 3 janvier 2013<\/span><\/b>
\nCompositions for the treatment of Fragile X Syndrome
\nInventeurs : S Briault et O Perche<\/o:p><\/span><\/p>

 <\/span><\/p>

Brevet WO2009\/153434 A2 (Publication date: 2009-12-23)<\/span><\/b>
\nBrevet d\u00e9pos\u00e9 \u00e0 l\u2019INPI le 23.05.2008 : N\u00b0 0853357
\nAnalogues synth\u00e9tiques des phosphatidyl-myo-inositol mannosides pourvus d\u2019une\nactivit\u00e9 inhibitrice de la r\u00e9ponse inflammatoire
\nInventeurs : V. Quesniaux (IEM, CNRS), O. Martin (ICOA, UniOrl\u00e9ans), S.\nFront (IEM, CNRS)<\/o:p><\/span><\/p>

 <\/span><\/p>

Brevet\neurop\u00e9en d\u00e9pos\u00e9 le 18.09.2008 : N\u00b0 EP08305565.7<\/span><\/b>
\nI. Use of a compound capable of reducing the uric acid level for the prevention\nand\/or the treatment of lung inflammation and fibrosis
\nInventeurs: B. Ryffel et I. Couillin<\/o:p><\/span><\/p>

 <\/span><\/p>

Brevet WO2008\/068429 (Publication date: 2008-06-12)<\/span><\/b>
\nPCT\/FR2007\/001898 (20.11.2007), extension du FR\/ 06\/10136 d\u00e9pos\u00e9 le 20.11.2006
\nComposition pour la pr\u00e9vention ou le traitement des maladies associ\u00e9es \u00e0 la\nsurexpression du TNF et\/ou de l\u2019IL-12
\nInventeurs : V.Quesniaux (IEM, CNRS) et G.Puzo, M.Gilleron, J.Nigou (IPBS,\nCNRS)<\/o:p><\/span><\/p>

 <\/span><\/p>

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<\/p>

Brevet\neurop\u00e9en d\u00e9pos\u00e9 le 24.7.2002 : N\u00b0 02 291 8791<\/span><\/b>
\nMethod for identifying biologically active compounds with anti-asthmatic,\nanti-allergic and\/or immunosuppressive properties.
\n<\/span>Inventeurs :\nI.Couillin (Key-Obs) et B.Ryffel (CNRS)<\/o:p><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Liste des brevets Brevet europ\u00e9en d\u00e9pos\u00e9 le 04 mars 2021 : N\u00b0 EP21305260 USE OF A PERIOSTIN ANTIBODY FOR TREATING INFLAMMATION, FIBROSIS AND LUNG DISEASESInventeurs : M.Perez-Cruz et B.Ryffel (CNRS) Brevet WO\/2013\/001412 publi\u00e9 le 3 janvier 2013 Compositions for the treatment of Fragile X Syndrome Inventeurs : S Briault et O Perche   Brevet WO2009\/153434…
Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1760","page","type-page","status-publish","hentry"],"yoast_head":"\nINEM Brevets -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INEM Brevets -\" \/>\n<meta property=\"og:description\" content=\"Liste des brevets Brevet europ\u00e9en d\u00e9pos\u00e9 le 04 mars 2021 : N\u00b0 EP21305260 USE OF A PERIOSTIN ANTIBODY FOR TREATING INFLAMMATION, FIBROSIS AND LUNG DISEASESInventeurs : M.Perez-Cruz et B.Ryffel (CNRS) Brevet WO\/2013\/001412 publi\u00e9 le 3 janvier 2013 Compositions for the treatment of Fragile X Syndrome Inventeurs : S Briault et O Perche   Brevet WO2009\/153434… Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/\" \/>\n<meta property=\"og:site_name\" content=\"INEM\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-02T11:19:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/index.php\\\/brevets\\\/\",\"url\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/index.php\\\/brevets\\\/\",\"name\":\"INEM Brevets -\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/#website\"},\"datePublished\":\"2023-01-02T13:29:51+00:00\",\"dateModified\":\"2023-02-02T11:19:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/index.php\\\/brevets\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.inem.cnrs.fr\\\/index.php\\\/brevets\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/index.php\\\/brevets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brevets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/#website\",\"url\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/\",\"name\":\"INEM Immuno-Neuro Modulation\",\"description\":\"\",\"alternateName\":\"INEM\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.inem.cnrs.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INEM Brevets -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/","og_locale":"fr_FR","og_type":"article","og_title":"INEM Brevets -","og_description":"Liste des brevets Brevet europ\u00e9en d\u00e9pos\u00e9 le 04 mars 2021 : N\u00b0 EP21305260 USE OF A PERIOSTIN ANTIBODY FOR TREATING INFLAMMATION, FIBROSIS AND LUNG DISEASESInventeurs : M.Perez-Cruz et B.Ryffel (CNRS) Brevet WO\/2013\/001412 publi\u00e9 le 3 janvier 2013 Compositions for the treatment of Fragile X Syndrome Inventeurs : S Briault et O Perche   Brevet WO2009\/153434… Read more","og_url":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/","og_site_name":"INEM","article_modified_time":"2023-02-02T11:19:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/","url":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/","name":"INEM Brevets -","isPartOf":{"@id":"https:\/\/www.inem.cnrs.fr\/#website"},"datePublished":"2023-01-02T13:29:51+00:00","dateModified":"2023-02-02T11:19:25+00:00","breadcrumb":{"@id":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.inem.cnrs.fr\/index.php\/brevets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.inem.cnrs.fr\/"},{"@type":"ListItem","position":2,"name":"Brevets"}]},{"@type":"WebSite","@id":"https:\/\/www.inem.cnrs.fr\/#website","url":"https:\/\/www.inem.cnrs.fr\/","name":"INEM Immuno-Neuro Modulation","description":"","alternateName":"INEM","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.inem.cnrs.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/pages\/1760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/comments?post=1760"}],"version-history":[{"count":18,"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/pages\/1760\/revisions"}],"predecessor-version":[{"id":3292,"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/pages\/1760\/revisions\/3292"}],"wp:attachment":[{"href":"https:\/\/www.inem.cnrs.fr\/index.php\/wp-json\/wp\/v2\/media?parent=1760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}